Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jarvis

Showing results (231-240 of 234) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 234 results.
The Journal of Infectious Diseases|February 25, 2016
A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody ResponseAnna P Durbin, Beth D Kirkpatrick, Kristen K Pierce, et al.
The Journal of Infectious Diseases|March 25, 2015
Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive AdultsBeth D Kirkpatrick, Anna P Durbin, Kristen K Pierce, et al.
Anti-Cancer Drugs|October 14, 2005
A highly potent and selective farnesyltransferase inhibitor ABT-100 in preclinical studiesWen-Zhen Gu, Ingrid Joseph, Yi-Chun Wang, et al.
Advanced Healthcare Materials|June 26, 2024
Study of the Structure of Hyperbranched Polyglycerol Coatings and Their Antibiofouling and Antithrombotic ApplicationsEli Moore, Alexander J Robson, Amy R Crisp, et al.
Pageof 24

Showing results (231-240 of 234) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 234 results.
The Journal of Infectious Diseases|February 25, 2016
A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody ResponseAnna P Durbin, Beth D Kirkpatrick, Kristen K Pierce, et al.
The Journal of Infectious Diseases|March 25, 2015
Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive AdultsBeth D Kirkpatrick, Anna P Durbin, Kristen K Pierce, et al.
Anti-Cancer Drugs|October 14, 2005
A highly potent and selective farnesyltransferase inhibitor ABT-100 in preclinical studiesWen-Zhen Gu, Ingrid Joseph, Yi-Chun Wang, et al.
Advanced Healthcare Materials|June 26, 2024
Study of the Structure of Hyperbranched Polyglycerol Coatings and Their Antibiofouling and Antithrombotic ApplicationsEli Moore, Alexander J Robson, Amy R Crisp, et al.
Pageof 24